Mycobacterial Infections – PST05103 Pharmaceutical Microbiology
NTA Level 5 • Semester 1 • PST05103 Mycobacterial Infections Pharmaceutical Microbiology • Source Session/Topic 17 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 17: Mycobacterial Infections Total Session Time: 120 minutes Pre-requisites • Human anatomy and physiology Students Learning Tasks By the end of this session students are expected to be able to: • Describe mycobacterium infection(causative agents, transmission, signs and symptoms) • Describe treatment, prevention and control of mycobacterial infection Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers SESSION OVERVIEW |Step |Time |Activity/ |Content | | | |Method | | |1 |5 minutes |Presentation |Introduction, Learning Tasks | |2 | |Buzzing/ |Cause and Transmission of | | |25 minutes |Presentation |Tuberculosis | |3 |10 minutes |Presentation |Signs and Symptoms of Tuberculosis| |4 |25 minutes |Brainstorming/|Treatment, Prevention and Control | | | |Presentation |of Tuberculosis | |5 |15 minutes |Presentation |Cause and Transmission of Leprosy | |6 | 10 minutes|Presentation |Signs and Symptoms of Leprosy | |7 |20 minutes |Presentation |Treatment, Prevention and Control | | | | |of Leprosy | |9 |5 minutes |Presentation |Key Points | | |5 minutes |Presentation |Evaluation | |10 | | | | SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning tasks and clarify ASK students if they have any questions before continuing STEP 2: Cause and Transmission of Tuberculosis (25 minutes) |Activity: Buzzing (5 minutes) | | | |ASK students to pair up and buzz on the following question for 2 | |minutes | | | |What is the cause and transmission of Tuberculosis?? | | | |ALLOW few pairs to respond and let other pairs to add on points | |not mentioned | | | |WRITE their response on the flip chart/board | | | |CLARIFY and SUMMARIZE by using the content below | • • Tuberculosis (TB) is a chronic, progressive airborne mycobacterial infection, often with a period of latency following initial infection. TB most commonly affects the lungs • Tuberculosis is caused by Mycobacterium tuberculosis (for which humans are the main reservoir) o Similar disease occasionally results from the closely related mycobacteria, M. bovis, M. africanum, and M. microti—which together with M. tuberculosis are known as the Mycobacterium tuberculosis complex • Tuberculosis is transmitted through inhalation of airborne particles (droplet nuclei) containing M. tuberculosis. o Mycobacteria disperse primarily through coughing, singing, and other forced respiratory maneuvers by people who have active pulmonary or laryngeal TB • Mycobacteria are slender, curved, acid-fast bacilli that belong to the family Mycobacteriaceae • Types of Tuberculosis o Pulmonary TB ▪ It is the most common and infectious affecting the lungs o Extra pulmonary TB ▪ This type of TB occurs when bacteria spread outside the lung to cause damage in any organ such as meninges, lymphnodes, kidneys, spine, intestinal and ostearticular ▪ It common among people with HIV/AIDS • Tuberculosis occurs in three forms, primary infection (usually asymptomatic), latent infection (dormant stage) and active infection. STEP 3: Signs and Symptoms of Tuberculosis (10 minutes) • Cough of more than two weeks • Fever • Excessive Night sweats • Haemoptysis (sputum mixed with blood stains) • Loss of weight • Fatigue • Chest pain • Anorexia STEP 4: Treatment, Prevention and Control of Tuberculosis (25 minutes) • Combination of antituberculosis drugs is used to avoid emergence of drug resistance • Compliance must be ensured before initiation of therapy • Antituberculosis (Anti-TB) drugs are; o First line drugs ▪ Isoniazid ▪ Rifampicin ▪ Pyrazinamide ▪ Ethambutol ▪ Streptomycin o Second line drugs include; ▪ Kanamycin ▪ Capreomycin ▪ Ethionamide ▪ Cycloserin ▪ Ofloxacin • According to National TB and Leprosy programme (NTLP) patients are grouped into three categories namely category I, II and III o Combination of anti-Tb drugs into regimens is based on these categories • Considerations in provision of anti-Tb drugs o HIV/AIDS and other chronic diseases e.g. liver failure o Oral contraceptive use o Pregnancy o Breastfeeding o Drug resistance ▪ Multidrug resistance tuberculosis • Prevention and control o Treatment of patients with active tuberculosis o Treating causes of immune suppression o Immunization with BCG vaccine o Pasteurization of milk o Isolation of patients |Activity: Take home Assignment (10 minutes) | | | |DIVIDE students in groups or individual. | | | |ASK the students to work on the following assignment | | | |What are the regimens (drug, dose and schedule) used for treatment of | |tuberculosis in different patients? | | | |ALLOCATE time for students to do the assignment and submit | | | |REFER students to recommended references | STEP 5: Cause and Transmission of Leprosy (15 minutes) • Leprosy is a chronic granulomatous disease caused by Mycobacterium leprae • The disease mainly affects the skin, the peripheral nerves and the mucous memberanes, usually affecting the cooler parts of the body such as skin, nose and upper respiratory tract • Leprosy is a disease mainly of human beings, which affects people of all races, all ages and both sexes • Leprosy is the commonest cause of peripheral neuritis in the world • Leprosy is transmitted through prolonged contact with patients with lepromatous leprosy who discharge large numbers of M. leprae in nasal secretions and from skin lesions • There three forms of leprosy namely tuberculoid leprosy, lepromatous leprosy and a mixture of the two o Tuberculoid leprosy the disease is non-progressive and benign o Lepromatous leprosy the disease is progressive and malignant STEP 6: Signs and Symptoms of Leprosy (10 minutes) • The major clinical features therefore include hypopigmented anaesthetic macula or nodular and erythematous skin lesions and nerve thickening • Patients is suspected of having leprosy when they show one or more of the following signs of symptoms: o Burning sensations in the skin o Pale patches on the skin with loss of feeling o